TCI Wealth Advisors, Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,122
+18.2%
2190.0%0.00%
Q4 2022$3,486
-75.1%
219
-61.2%
0.00%
-100.0%
Q1 2022$14,000
+7.7%
5640.0%0.00%0.0%
Q4 2021$13,000
+85.7%
564
+28.5%
0.00%
+100.0%
Q3 2021$7,000
+16.7%
439
+86.0%
0.00%
-66.7%
Q1 2021$6,000
-25.0%
236
+57.3%
0.00%
-25.0%
Q4 2020$8,000
+33.3%
1500.0%0.00%
+100.0%
Q3 2020$6,000
-50.0%
150
-40.0%
0.00%
-60.0%
Q2 2020$12,000
+9.1%
2500.0%0.01%0.0%
Q1 2020$11,000
+22.2%
250
+25.0%
0.01%
+66.7%
Q4 2019$9,000
-18.2%
200
-33.3%
0.00%
-40.0%
Q3 2019$11,000
-31.2%
300
-50.0%
0.01%
-28.6%
Q2 2019$16,0000.0%6000.0%0.01%0.0%
Q1 2019$16,000
+60.0%
6000.0%0.01%
+40.0%
Q4 2018$10,000
-41.2%
600
-25.7%
0.01%
-28.6%
Q3 2018$17,000
+6.2%
807
-21.0%
0.01%0.0%
Q2 2018$16,000
-52.9%
1,021
-31.9%
0.01%
-56.2%
Q1 2018$34,000
-35.8%
1,500
-14.3%
0.02%
-30.4%
Q4 2017$53,000
-11.7%
1,750
+9.4%
0.02%
-20.7%
Q3 2017$60,000
+27.7%
1,600
-5.9%
0.03%
+20.8%
Q2 2017$47,000
-16.1%
1,700
+5.1%
0.02%
-17.2%
Q1 2017$56,000
+19.1%
1,6180.0%0.03%
+16.0%
Q4 2016$47,000
-2.1%
1,618
+6.6%
0.02%
-3.8%
Q3 2016$48,000
+6.7%
1,518
+8.4%
0.03%
+4.0%
Q2 2016$45,000
-2.2%
1,400
+7.7%
0.02%
-3.8%
Q4 2015$46,000
+7.0%
1,3000.0%0.03%0.0%
Q3 2015$43,000
-17.3%
1,300
+4.0%
0.03%
-13.3%
Q2 2015$52,000
+26.8%
1,2500.0%0.03%
+15.4%
Q1 2015$41,0001,2500.03%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders